Disclosures for "Case of a Pure Arterial Malformation and Review of the Literature.")
-
Dr. Ahmed has nothing to disclose.
-
Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. The institution of Dr. Regenhardt has received research support from NINDS. The institution of Dr. Regenhardt has received research support from SVIN.
-
Dr. Vranic has nothing to disclose.
-
Dr. Dmytriw has nothing to disclose.
-
James D. Rabinov has stock in Pfizer.